Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Major Depression in Schizophrenia
NCT04001439Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Dec 2019
- Primary completion
- Feb 2020
- Modality
- Live Biotherapeutic Products
01
Overview
Open-label, single-arm trial of allogeneic fecal microbiota in major depressive disorder (MDD), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoints: Depressive score at 2 months, Adverse events at 2 months and 2 more. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04001439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04001439.